Point-of-care tests for infection control: Should rapid testing be in the laboratory or at the front line?

Journal of Hospital Infection

Volumn 85, Issue 1, 2013, Pages 1-7

  Moore, C ^a  

^a UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Infection control; Influenza; Norovirus; Rapid test; Respiratory syncytial virus

Indexed keywords

DIAGNOSTIC KIT; EPIDEMIC; HOSPITAL INFECTION; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; INFECTION CONTROL; INFLUENZA VIRUS; MEDLINE; NOROVIRUS; POINT OF CARE TESTING; PREDICTIVE VALUE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW;

EID: 84881665669     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2013.06.005     Document Type: Review

References (71)

1. Plebani M. Does POCT reduce the risk of error in laboratory testing?. Clin Chim Acta 2009, 404:59-64.
2. Anonymous Clinical laboratory improvement amendments (CLIA) 2009, US Department of Health & Human Services, Washington DC.
3. Anonymous Nosocomial hepatitis B virus infection associated with reusable fingerstick blood sampling devices - Ohio and New York City, 1996. Morb Mortal Wkly Rep 1997, 46:217-221.
4. Perz J.F., Fiore A.E. Hepatitis B virus infection risks among diabetic patients residing in long-term care facilities. Clin Infect Dis 2005, 41:760-761.
5. Patel A.S., White-Comstock M.B., Woolard C.D., Perz J.F. Infection control practices in assisted living facilities: a response to hepatitis B virus infection outbreaks. Infect Control Hosp Epidemiol 2009, 30:209-214.
6. Duffell E.F., Milne L.M., Seng C., et al. Five hepatitis B outbreaks in care homes in the UK associated with deficiencies in infection control practice in blood glucose monitoring. Epidemiol Infect 2011, 139:327-335.
7. Anonymous Management and use of IVD point of care test devices 2010, Healthcare Products Regulatory Agency, London.
8. Hicks J.M., Haeckel R., Price C.P., Lewandrowski K., Wu A.H. Recommendations and opinions for the use of point-of-care testing for hospitals and primary care: summary of a 1999 symposium. Clin Chim Acta 2001, 303:1-17.
9. Lewandrowski K., Gregory K., Macmillan D. Assuring quality in point-of-care testing: evolution of technologies, informatics, and program management. Arch Pathol Lab Med 2011, 135:1405-1414.
10. Fox J.W., Cohen D.M., Marcon M.J., Cotton W.H., Bonsu B.K. Performance of rapid streptococcal antigen testing varies by personnel. JClin Microbiol 2006, 44:3918-3922.
11. Bamberg R., Schulman K., MacKenzie M., Moore J., Olchesky S. Effect of adverse storage conditions on performance of glucometer test strips. Clin Lab Sci 2005, 18:203-209.
12. Anonymous CDC launching new era in testing by giving OK to rapid screening tests. AIDS Alert 1998, 13:25-27.
13. Manning L., Laman M., Rosanas-Urgell A., et al. Rapid antigen detection tests for malaria diagnosis in severely ill Papua New Guinean children: a comparative study using Bayesian latent class models. PLoS One 2012, 7:e48701.
14. Torane V.P., Shastri J.S. Comparison of ELISA and rapid screening tests for the diagnosis of HIV, hepatitis B and hepatitis C among healthy blood donors in a tertiary care hospital in Mumbai. Indian J Med Microbiol 2008, 26:284-285.
15. Appiah L.T., Havers F., Gibson J., Kay M., Sarfo F., Chadwick D. Efficacy and acceptability of rapid, point-of-care HIV testing in two clinical settings in Ghana. AIDS Patient Care STDS 2009, 23:365-369.
16. Iregbu K.C., Esfandiari J., Nnorom J., et al. Dual Path Platform HIV 1/2 assay: evaluation of a novel rapid test using oral fluids for HIV screening at the National Hospital in Abuja, Nigeria. Diagn Microbiol Infect Dis 2011, 69:405-409.
17. Ashby J., Braithewaite B., Walsh J., Gnani S., Fidler S., Cooke G. HIV testing uptake and acceptability in an inner city polyclinic. AIDS Care 2012, 24:905-909.
18. Gaydos C.A., Hsieh Y.H., Harvey L., et al. Will patients "opt in" to perform their own rapid HIV test in the emergency department?. Ann Emerg Med 2011, 58(1 Suppl. 1):S74-S78.
19. Burns F., Edwards S.G., Woods J., et al. Acceptability and feasibility of universal offer of rapid point of care testing for HIV in an acute admissions unit: results of the RAPID project. PLoS One 2012, 7:e35212.
20. Schimke I. Quality and timeliness in medical laboratory testing. Analyt Bioanalyt Chem 2009, 393:1499-1504.
21. Blyth C.C., Booy R., Dwyer D.E. Point of care testing: diagnosis outside the virology laboratory. Methods Mol Biol 2011, 665:415-433.
22. Kaklikkaya N., Akdogan R.A., Ozgur O., et al. Evaluation of a new rapid lateral flow chromatography test for the diagnosis of Helicobacter pylori. Saudi Med J 2006, 27:799-803.
23. Laderman E.I., Whitworth E., Dumaual E., et al. Rapid, sensitive, and specific lateral-flow immunochromatographic point-of-care device for detection of herpes simplex virus type 2-specific immunoglobulin G antibodies in serum and whole blood. Clin Vaccine Immunol 2008, 15:159-163.
24. Sharp S.E., Ruden L.O., Pohl J.C., Hatcher P.A., Jayne L.M., Ivie W.M. Evaluation of the C.Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. JClin Microbiol 2010, 48:2082-2086.
25. Thornton C., Johnson G., Agrawal S. Detection of invasive pulmonary aspergillosis in haematological malignancy patients by using lateral-flow technology. JVis Exp 2012, (61). pii: 3721.
26. Wiriyachaiporn S., Howarth P.H., Bruce K.D., Dailey L.A. Evaluation of a rapid lateral flow immunoassay for Staphylococcus aureus detection in respiratory samples. Diagn Microbiol Infect Dis 2013, 75:28-36.
27. Wiwanitkit V. POCT test for swine flu. JInfect Public Health 2011, 4:217.
28. Pastoor R., Hatta M., Abdoel T.H., Smits H.L. Simple, rapid, and affordable point-of-care test for the serodiagnosis of typhoid fever. Diagn Microbiol Infect Dis 2008, 61:129-134.
29. Hesselink D.A., Burgerhart J.S., Bosmans-Timmerarends H., Petit P., van Genderen P.J. Procalcitonin as a biomarker for severe Plasmodium falciparum disease: a critical appraisal of a semi-quantitative point-of-care test in a cohort of travellers with imported malaria. Malar J 2009, 8:206.
30. Leyland B., Kennedy M.R., Wimberly Y.H., Levine B.J., Cherpes T.L. Serologic detection of herpes simplex virus type 2 antibodies among pregnant women using a point-of-care test from Focus Diagnostics. JClin Virol 2009, 44:125-128.
31. Sabido M., Hernandez G., Gonzalez V., et al. Clinic-based evaluation of a rapid point-of-care test for detection of Chlamydia trachomatis in specimens from sex workers in Escuintla, Guatemala. JClin Microbiol 2009, 47:475-476.
32. Sturenburg E., Junker R. Point-of-care testing in microbiology: the advantages and disadvantages of immunochromatographic test strips. Dtsch Arztebl Int 2009, 106:48-54.
33. Rashid H., Shafi S., Haworth E., et al. Value of rapid testing for influenza among Hajj pilgrims. Travel Med Infect Dis 2007, 5:310-313.
34. Steininger C., Redlberger M., Graninger W., Kundi M., Popow-Kraupp T. Near-patient assays for diagnosis of influenza virus infection in adult patients. Clin Microbiol Infect 2009, 15:267-273.
35. Khamon A.B., Velvin C., Hawrami K., et al. Performance of a nurse-led paediatric point of care service for respiratory syncytial virus testing in secondary care. J Infect 2010, 62:52-58.
36. Yamazaki M., Mitamura K., Kimura K., et al. [Clinical evaluation of an immunochromatography test for rapid diagnosis of influenza]. Kansenshogaku Zasshi 2001, 75:1047-1053.
37. Arsene S., Vabret A., Dina J., et al. Comparison of the quick view influenza test (Quidel) to an immunofluorescence assay for the detection of influenza virus infections. Roum Arch Microbiol Immunol 2004, 63:235-243.
38. Sintchenko V., Gilbert G.L., Coiera E., Dwyer D. Treat or test first? Decision analysis of empirical antiviral treatment of influenza virus infection versus treatment based on rapid test results. JClin Virol 2002, 25:15-21.
39. Vasoo S., Stevens J., Singh K. Rapid antigen tests for diagnosis of pandemic (Swine) influenza A/H1N1. Clin Infect Dis 2009, 49:1090-1093.
40. Hurt A.C., Baas C., Deng Y.M., Roberts S., Kelso A., Barr I.G. Performance of influenza rapid point-of-care tests in the detection of swine lineage A(H1N1) influenza viruses. Influenza Other Resp Viruses 2009, 3:171-176.
41. Stripeli F., Sakkou Z., Papadopoulos N., et al. Performance of rapid influenza testing in hospitalized children. Eur J Clin Microbiol Infect Dis 2010, 29:683-688.
42. Fernandez C., Cataletto M., Lee P., Feuerman M., Krilov L. Rapid influenza A testing for novel H1N1: point-of-care performance. Postgrad Med 2010, 122:28-33.
43. Anonymous Evaluation of 11 commercially available rapid influenza diagnostic tests - United States, 2011-2012. Morb Mortal Wkly Rep 2012, 61:873-876.
44. Balish A., Garten R., Klimov A., Villanueva J. Analytical detection of influenza A(H3N2)v and other A variant viruses from the USA by rapid influenza diagnostic tests. Influenza Other Resp Viruses 2013, 7:491-496.
45. Anonymous Evaluation of rapid influenza diagnostic tests for influenza A (H3N2)v virus and updated case count - United States, 2012. Morb Mortal Wkly Rep 2012, 61:619-621.
46. Mackie P.L., McCormick E.M., Williams C. Evaluation of Binax NOW RSV as an acute point-of-care screening test in a paediatric accident and emergency unit. Commun Dis Public Health 2004, 7:328-330.
47. Mills J.M., Harper J., Broomfield D., Templeton K.E. Rapid testing for respiratory syncytial virus in a paediatric emergency department: benefits for infection control and bed management. JHosp Infect 2011, 77:248-251.
48. Scharff R.L. Economic burden from health losses due to foodborne illness in the United States. JFood Prot 2012, 75:123-131.
49. Zakikhany K., Allen D.J., Brown D., Iturriza-Gomara M. Molecular evolution of GII-4 Norovirus strains. PLoS One 2012, 7:e41625.
50. Chen S.Y., Chiu C.H. Worldwide molecular epidemiology of norovirus infection. Paediatr Int Child Health 2012, 32:128-131.
51. Kirby A., Gurgel R.Q., Dove W., Vieira S.C., Cunliffe N.A., Cuevas L.E. An evaluation of the RIDASCREEN and IDEIA enzyme immunoassays and the RIDAQUICK immunochromatographic test for the detection of norovirus in faecal specimens. JClin Virol 2010, 49:254-257.
52. Ambert-Balay K., Pothier P. Evaluation of 4 immunochromatographic tests for rapid detection of norovirus in faecal samples. JClin Virol 2012, 56:194-198.
53. Pombubpa K., Kittigul L. Assessment of a rapid immunochromatographic test for the diagnosis of norovirus gastroenteritis. Eur J Clin Microbiol Infect Dis 2012, 31:2379-2383.
54. Battaglioli G., Nazarian E.J., Lamson D., Musser K.A. St George K. Evaluation of the RIDAQuick norovirus immunochromatographic test kit. JClin Virol 2012, 53:262-264.
55. Geginat G., Kaiser D., Schrempf S. Evaluation of third-generation ELISA and a rapid immunochromatographic assay for the detection of norovirus infection in fecal samples from inpatients of a German tertiary care hospital. Eur J Clin Microbiol Infect Dis 2012, 31:733-737.
56. Beersma M.F., Sukhrie F.H., Bogerman J., et al. Unrecognized norovirus infections in health care institutions and their clinical impact. JClin Microbiol 2012, 50:3040-3045.
57. Trivedi T.K., DeSalvo T., Lee L., et al. Hospitalizations and mortality associated with norovirus outbreaks in nursing homes, 2009-2010. JAMA 2012, 308:1668-1675.
58. Kak V. Infections in confined spaces: cruise ships, military barracks, and college dormitories. Infect Dis Clin North Am 2007, 21:773-784. ix-x.
59. Vivancos R., Keenan A., Sopwith W., et al. Norovirus outbreak in a cruise ship sailing around the British Isles: investigation and multi-agency management of an international outbreak. JInfect 2010, 60:478-485.
60. Jenny S.L., Hu Y., Overduin P., Meijer A. Evaluation of the Xpert Flu A Panel nucleic acid amplification-based point-of-care test for influenza A virus detection and pandemic H1 subtyping. JClin Virol 2010, 49:85-89.
61. Popowitch E.B., Rogers E., Miller M.B. Retrospective and prospective verification of the Cepheid Xpert influenza virus assay. JClin Microbiol 2011, 49:3368-3369.
62. Brenwald N.P., Baker N., Oppenheim B. Feasibility study of a real-time PCR test for meticillin-resistant Staphylococcus aureus in a point of care setting. JHosp Infect 2010, 74:245-249.
63. Shin S., Kim M., Kim M., et al. Evaluation of the Xpert Clostridium difficile assay for the diagnosis of Clostridium difficile infection. Ann Lab Med 2012, 32:355-358.
64. Boehme C.C., Nicol M.P., Nabeta P., et al. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011, 377:1495-1505.
65. Banada P.P., Sivasubramani S.K., Blakemore R., et al. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. JClin Microbiol 2010, 48:3551-3557.
66. Cohen-Bacrie S., Ninove L., Nougairede A., et al. Revolutionizing clinical microbiology laboratory organisation in hospitals with in situ point-of care. PLoS One 2011, http://dx.doi.org/10.1371/journal.pone.0022403. e22403.
67. Lee-Lewandrowski E., Corboy D., Lewandrowski K., Sinclair J., McDermot S., Benzer T.I. Implementation of a point-of-care satellite laboratory in the emergency department of an academic medical center. Impact on test turnaround time and patient emergency department length of stay. Arch Pathol Lab Med 2003, 127:456-460.
68. Poehling K.A., Zhu Y., Tang Y.W., Edwards K. Accuracy and impact of a point-of-care rapid influenza test in young children with respiratory illnesses. Arch Pediatr Adolesc Med 2006, 160:713-718.
69. Rath B., Tief F., Obermeier P., et al. Early detection of influenza A and B infection in infants and children using conventional and fluorescence-based rapid testing. JClin Virol 2012, 55:329-333.
70. van Doorn H.R., van Kinh N., Tuan H.M., et al. Clinical validation of a point of care multiplexed invitro immunoassay using monoclonal antibodies (the MSD influenza test) in four hospitals in Vietnam. JClin Microbiol 2012, 50:1621-1625.
71. Shu P.Y., Yang C.F., Kao J.F., et al. Application of the dengue virus NS1 antigen rapid test for on-site detection of imported dengue cases at airports. Clin Vaccine Immunol 2009, 16:589-591.